Myomar Molecular: Funding, Investors & Team (Sep 2026)
Myomar Molecular is creating a diagnostic tool that can detect the early signs of muscle wasting. This technology will aid physiotherapists and doctors in determining treatment plans, decreasing time spent in the hospital, and tracking the progress of recovery.
Myomar Molecular has raised $810k across 2 funding rounds on record, the most recent an undisclosed round of $810k announced in Mar 2024.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Myomar Molecular Company Profile and Key Stats
Latest funding round on record: Mar 2024.
Myomar Molecular Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Myomar Molecular announced an undisclosed round in Aug 2023; the amount was not disclosed.
7 months later, an undisclosed round of $810k was announced in Mar 2024.
Myomar Molecular Founders and Leadership Team
No contact details are on record for this team yet.
Myomar Molecular Funding Compared to Other Health Care Startups
Myomar Molecular's latest round of $810k is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Myomar Molecular in Health Care and Halifax
Companies Similar to Myomar Molecular
Cuffway develops medical devices for automated, real-time regulation of endotracheal tube cuff pressure to…
Principal Technologies is a Canadian business that invests in healthcare technologies.
Developing Life Altering Treatments for Patients Suffering from Rare Chronic Diseases.
Optimi Health is a supplier of natural, pharmaceutical-grade psilocybin and synthetic psychedelic compounds.…
Kare specializes in the research, development, and commercialization of catalysts, precursors, and industrial…
Synakis patented a biodegradable hydrogel vitreous substitute that is injectable, non-cytotoxic in vitro and…
Canadian Coalition for Seniors' Mental Health works to promote seniors' mental health by connecting people,…
Jack.org is a charitable group that instructs and strengthens young pioneers to change the field of mental…
Aplantex produces plant-based active compounds for application in the pharma, cosmetics, and agri-food…
Perimeter Medical Imaging is a medical technology company driven to transform cancer surgery with ultra-high…
Leveljump Healthcare offers radiology solutions for hospitals, emergency rooms, and private clinics. They…
Psyched Wellness is a Canadian-based company improving the health and wellness of millions with high-quality…
Myomar Molecular Funding FAQs
What does Myomar Molecular do?
Myomar Molecular is creating a diagnostic tool that can detect the early signs of muscle wasting. This technology will aid physiotherapists and doctors in determining treatment plans, decreasing time spent in the hospital, and tracking the progress of recovery.
How much funding has Myomar Molecular raised?
Myomar Molecular has raised $810k across 2 rounds on record. The most recent is an undisclosed round of $810k announced in Mar 2024.
When did Myomar Molecular last raise funding?
Myomar Molecular's most recent funding round on record is an undisclosed round of $810k, announced in Mar 2024.
Who founded Myomar Molecular?
FundedIQ lists Rafaela Andrade (Founder) at Myomar Molecular.
Where is Myomar Molecular headquartered?
Myomar Molecular is based in Halifax, Nova Scotia, Canada.
How many employees does Myomar Molecular have?
Myomar Molecular is in the 1-10 employee band.
How does Myomar Molecular's funding compare to other Health Care startups?
Myomar Molecular's latest round of $810k is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Myomar Molecular Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Myomar Molecular is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.